Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024

/PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi during the first...

Related Keywords

Sweden ,Japan ,Stockholm ,China ,Swedish ,Lecanemab Leqembi ,Jiang Millington ,Oskar Bosson ,National Institute On ,European Union ,Washington University School Of Medicine ,Vp Communications ,National Institutes Of Health ,Alzheimer Network Trials Unit ,Alzheimer Clinical Trial Consortium ,Nasdaq Stockholm ,Director Corporate Communication ,Social Media ,New England Journal ,Clinical Trial Consortium ,National Institute ,National Institutes ,Tau Nexgen ,Dominantly Inherited ,Washington University School ,Commercialization Agreement ,Nasdaq Stockholm Large ,Bioarctic ,